| |
|
|
|
Citius Pharmaceuticals Inc.  
|
|
1.1 0 (0%) |
06-21 16:00 |
|
Open: |
1.09 |
Pre close: |
1.1 |
Target:
|
1.53
|
|
High: |
1.1446 |
Low: |
1.07 |
Resistance:
|
1.31
1.50
|
|
Volume: |
102,337 |
Market Cap: |
24M |
Support:
|
1.01
0.84
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.11
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.13  |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
1.17 |
Stochastic Oscillator |
%K(14,3):
|
40.00 |
|
MA(250): |
1.43 |
%D(3): |
38.71 |
|
Average Volume(K) |
3-Month: |
17389
|
52-Week |
High:
|
3.15 |
|
10-Days: |
8148 |
Low: |
0.86 |
|
RSI |
RSI(14):
|
46.57 |
Change(%): |
-54.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.817 |
Return on Equity (ttm) |
-55.8 |
Shares Out. (M) |
22.08 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-32.8 |
Shares Float (M) |
7.87 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
43.10 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
4.20 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
74 |
|
Book Value (p.s.) |
1.120 |
EBITDA (p.s.) |
-0.597 |
P/E |
-1.35 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.98 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.76 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-6.64 |
P/CF |
-2.26 |
|
|
|
|
|
|
